These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

289 related articles for article (PubMed ID: 21747427)

  • 1. Beta agonist use during asthma exacerbations: how much is too much?
    Patel M; Perrin K; Beasley R
    N Z Med J; 2011 Apr; 124(1332):77-80. PubMed ID: 21747427
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Established combinations of inhaled corticoids and long-acting beta 2-symphathomimetics for long-term therapy of bronchial asthma. Position of an expert panel study].
    Buhl R; Kardos P; Magnussen H; Matthys H; Sauer R; Schauer P; Vogelmeier C; Wettengel R; Worth H; Menz G
    Pneumologie; 1999 Apr; 53(4):210-2. PubMed ID: 10409864
    [No Abstract]   [Full Text] [Related]  

  • 3. [Are there any advantages of a fixed combination in the treatment of asthma with respect to safety and tolerability?].
    Virchow C
    Dtsch Med Wochenschr; 2009 Dec; 134 Suppl 10():S376-80. PubMed ID: 19941240
    [No Abstract]   [Full Text] [Related]  

  • 4. [Combination treatment with inhaled corticosteroid/long-acting beta 2-adrenergic bronchodilator in the treatment of asthma].
    Kimura T; Adachi M
    Nihon Rinsho; 2001 Oct; 59(10):1992-9. PubMed ID: 11676144
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Do fixed combinations increase effectiveness in asthma bronchiale?].
    Vogelmeier C
    Dtsch Med Wochenschr; 2009 Dec; 134 Suppl 10():S372-5. PubMed ID: 19941239
    [No Abstract]   [Full Text] [Related]  

  • 6. [Fixed combination of inhalant steroids and long-acting beta(2) agonists].
    Petermann W; Mutschler E
    Dtsch Med Wochenschr; 2004 Jan; 129(5):210-4. PubMed ID: 14735419
    [No Abstract]   [Full Text] [Related]  

  • 7. Call for withdrawal of LABA single-therapy inhaler in asthma.
    Beasley R; Perrin K; Weatherall M; Wijesinghe M
    Lancet; 2010 Sep; 376(9743):750-1. PubMed ID: 20816529
    [No Abstract]   [Full Text] [Related]  

  • 8. [Combined inhaled corticosteroid and long-acting beta-2-agonist in one inhaler in the treatment of chronic obstructive pulmonary disease].
    Pedersen ST
    Ugeskr Laeger; 2005 Jun; 167(23):2504-6. PubMed ID: 16008004
    [No Abstract]   [Full Text] [Related]  

  • 9. Inhaled steroid/long-acting beta 2 agonist combination products provide 24 hours improvement in lung function in adult asthmatic patients.
    Lötvall J; Langley S; Woodcock A
    Respir Res; 2006 Aug; 7(1):110. PubMed ID: 16919161
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inhaled corticosteroid therapy in asthma: a balancing act.
    Li JT
    Ann Allergy Asthma Immunol; 1999 Mar; 82(3):229-30. PubMed ID: 10094213
    [No Abstract]   [Full Text] [Related]  

  • 11. FDA panel: ban 2 popular asthma drugs.
    Kuehn BM
    JAMA; 2009 Jan; 301(4):365-6. PubMed ID: 19176431
    [No Abstract]   [Full Text] [Related]  

  • 12. Combination inhalers containing inhaled corticosteroids and long-acting beta2-agonists: improved clinical efficacy and dosing options in patients with asthma.
    Ankerst J
    J Asthma; 2005 Nov; 42(9):715-24. PubMed ID: 16316864
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Long-acting beta(2)-adrenoceptor agonists for asthma and COPD].
    Rabe KF; Ukena D; Magnussen H
    Med Klin (Munich); 1997 Dec; 92 Suppl 5():44-9. PubMed ID: 19479397
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inhaled corticosteroids and long-acting beta-agonists in adult asthma: a winning combination in all?
    Postma DS; Kerstjens HA; ten Hacken NH
    Naunyn Schmiedebergs Arch Pharmacol; 2008 Aug; 378(2):203-15. PubMed ID: 18500509
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Predictors of severe exacerbations, poor asthma control, and β-agonist overuse for patients with asthma.
    Patel M; Pilcher J; Reddel HK; Qi V; Mackey B; Tranquilino T; Shaw D; Black P; Weatherall M; Beasley R;
    J Allergy Clin Immunol Pract; 2014; 2(6):751-8. PubMed ID: 25439367
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A retrospective database study comparing treatment outcomes and cost associated with choice of fixed-dose inhaled corticosteroid/long-acting beta-agonists for asthma maintenance treatment in Germany.
    Aballéa S; Cure S; Vogelmeier C; Wirén A
    Int J Clin Pract; 2008 Dec; 62(12):1870-9. PubMed ID: 18803555
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Long-acting inhaled beta(2)-agonist therapy in asthma.
    Kips JC; Pauwels RA
    Am J Respir Crit Care Med; 2001 Sep; 164(6):923-32. PubMed ID: 11587972
    [No Abstract]   [Full Text] [Related]  

  • 18. Adjustable maintenance dosing with budesonide/formoterol compared with fixed-dose salmeterol/fluticasone in moderate to severe asthma.
    Aalbers R; Backer V; Kava TT; Omenaas ER; Sandström T; Jorup C; Welte T
    Curr Med Res Opin; 2004; 20(2):225-40. PubMed ID: 15006018
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Managing a variable disease.
    Kips J
    Pulm Pharmacol Ther; 2002; 15(6):485-90. PubMed ID: 12493334
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Adrenal insufficiency during inhaled corticosteroid treatment in a child with asthma].
    Bjerre JV; Bender L; Naeraa RW; Rix M
    Ugeskr Laeger; 2008 Jun; 170(24):2161. PubMed ID: 18565305
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.